ng-nitroarginine methyl ester has been researched along with Autism Spectrum Disorder in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhandari, R; Kuhad, A; Mehta, R | 2 |
2 other study(ies) available for ng-nitroarginine methyl ester and Autism Spectrum Disorder
| Article | Year |
|---|---|
Exploring nordihydroguaretic acid (NDGA) as a plausible neurotherapeutic in the experimental paradigm of autism spectrum disorders targeting nitric oxide pathway.
Topics: Animals; Autism Spectrum Disorder; Benzyl Compounds; Butanes; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxidative Stress; Rats | 2021 |
Effects of catechin on a rodent model of autism spectrum disorder: implications for the role of nitric oxide in neuroinflammatory pathway.
Topics: Animals; Autism Spectrum Disorder; Catechin; Male; NF-kappa B; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxidative Stress; Rats | 2021 |